Hemoglobinopathies

Hemoglobinopathies: Basics & Beyond

• Hemoglobinopathy: Inherited disorders affecting globin chain structure or synthesis.
• Classification:
  • Structural: Altered globin (e.g., Sickle cell anemia, HbC).
  • Quantitative (Thalassemias): Reduced synthesis of normal globin chains.
• Normal Adult Hemoglobins:
  • HbA: $α_2β_2$ (>95%)
  • HbA2: $α_2δ_2$ (1.5-3.5%)
  • HbF: $α_2γ_2$ (<1-2%)

⭐ HbF (Fetal Hemoglobin) has a higher oxygen affinity than HbA, facilitating oxygen transfer from mother to fetus across the placenta.

Sickle Cell Saga: Bend & Break

• Pathophysiology: β-globin gene mutation ($Glu6Val$) leads to HbS. Under hypoxia, HbS polymerizes, causing RBCs to sickle.

• Clinical Features:
  • Vaso-occlusive Crises (VOC): Pain (dactylitis, acute chest syndrome, stroke).
  • Chronic Hemolysis: Anemia, jaundice, gallstones.
  • Aplastic Crisis: Parvovirus B19.
  • Functional asplenia: ↑ Infection risk.
• Diagnosis:
  • Screening: Sickling test (sodium metabisulfite).
  • Confirmatory: Hb electrophoresis or HPLC (shows HbS).
  • Peripheral smear: Sickled cells, Howell-Jolly bodies.
• Management Principles:
  • Avoid triggers, hydration, analgesia.
  • Hydroxyurea (↑ HbF).
  • Folic acid, infection prophylaxis (e.g., penicillin until age 5).
  • Transfusions for severe anemia/crisis.

⭐ Acute Chest Syndrome is a leading cause of death in sickle cell disease patients and is characterized by new pulmonary infiltrate on chest X-ray plus fever and/or respiratory symptoms.

Thalassemia Tales: Chain Reaction

• Pathophysiology: Reduced synthesis of α or β globin chains → imbalanced globin chain production, ineffective erythropoiesis.
• Types:

  Feature	Alpha (α) Thalassemia	Beta (β) Thalassemia
  Defect	Gene deletions (Chr 16)	Point mutations (Chr 11)
  Key Abnormal Hb	Hb Bart's (γ4), HbH (β4)	↑HbA2 (>3.5%), ↑HbF
  Severe Form	Hydrops fetalis (--/--)	Major (Cooley's Anemia - β0/β0)

• Clinical: Microcytic hypochromic anemia (↓MCV, ↓MCH), jaundice, splenomegaly, iron overload. "Crew-cut" skull X-ray (β-Major).
• Diagnosis: CBC, peripheral smear (target cells, anisopoikilocytosis); Hb electrophoresis/HPLC.

⭐ In β-Thalassemia Major, extramedullary hematopoiesis can lead to characteristic bone deformities like "crew-cut" skull on X-ray and hepatosplenomegaly due to ineffective erythropoiesis.

Hb Variants: The Odd Bunch

(β-globin) | $Glu26Lys## Hb Variants: The Odd Bunch

(β-globin) | Oxidized Heme (Fe³⁺) | | Key Clinical | Mild hemolytic anemia, target cells, crystals | SE Asia. Mild microcytic anemia, target cells | Cyanosis, chocolate blood. Normal $PaO_2## Hb Variants: The Odd Bunch

       |

| Treatment | Supportive | Supportive | Methylene blue |* HbD-Punjab: $Glu121Gln$ (β-globin). Common in NW India (Punjab). Mild hemolysis or asymptomatic. Homozygotes similar to sickle cell trait.

⭐ Methemoglobinemia: Arterial blood remains "chocolate-brown" despite O₂ exposure; pulse oximetry unreliable (~85%).

Detective Work: Spotting Hb Issues

Initial clues for hemoglobinopathies come from basic hematology. Further specialized tests confirm the diagnosis and type.

• Screening Tests:
  • CBC: RBC indices (MCV, MCH, MCHC).
  • Peripheral Smear: Morphology (sickled cells, target cells, Heinz bodies, basophilic stippling).
• Confirmatory Tests:
  • Hb Electrophoresis: Cellulose acetate (pH 8.6), Citrate agar (pH 6.2).
  • HPLC: Quantitative & qualitative assessment.
• Specific Tests:
  • Sickling Test (for HbS).
  • Kleihauer-Betke Test (quantifies HbF).
• Molecular Diagnosis:
  • DNA analysis: Specific mutations/deletions.

⭐ HPLC is currently the gold standard for neonatal screening and quantitative assessment of hemoglobin variants.

High‑Yield Points - ⚡ Biggest Takeaways

• Sickle Cell Anemia: β-globin gene mutation (GAG→GTG; Glu⁶→Val) forms HbS.
• HbS polymerizes under low O₂, causing sickling, vaso-occlusion, hemolysis.
• Hydroxyurea ↑ HbF, beneficial in Sickle Cell Disease.
• Thalassemias: Quantitative defect in globin synthesis; α-thalassemia (deletions), β-thalassemia (mutations).
• β-Thalassemia Major: Severe anemia, ineffective erythropoiesis; requires transfusions, iron chelation.
• ↑ HbA2 in β-thalassemia trait; ↑ HbF in severe β-thalassemias.
• Hb Bart's (γ₄) in α-thalassemia major (hydrops fetalis); HbH (β₄) in HbH disease.